WHO ICTRP trial
Study on Exemption from Radiotherapy for the rock tip of Stage T1-2…
ChiCTR2500113975 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113975 |
|---|---|
| Public title | Study on Exemption from Radiotherapy for the rock tip of Stage T1-2 Nasopharyngeal carcinoma |
| Scientific title | Study on Exemption from Radiotherapy for the rock tip of Stage T1-2 Nasopharyngeal carcinoma |
| Primary sponsor | Chongqing University Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Nasopharyngeal carcinoma |
| Interventions | Observation group of stage T1-2 nasopharyngeal carcinoma:None |
| Registration date | Dec 4, 2025 |
| Target size | Observation group of stage T1-2 nasopharyngeal carcinoma:300 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: